# Understanding Corticobasal Degeneration at Pacific Neuroscience Institute > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/corticobasal-degeneration-neuroprotection-cedclinic/ > **Published:** 2026-03-25T01:06:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:44-04:00 > **Clinical Summary:** Explore corticobasal degeneration neuroprotection and symptom management potential with cannabis at Pacific Neuroscience Institute. Learn more at CED Clinic. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Neurodegenerative DiseaseMovement DisordersPalliative CareNeuroprotection[Quality Of Life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/) Why This Matters Corticobasal degeneration (CBD) represents a rare but devastating neurodegenerative disorder where conventional treatments offer limited symptom relief. As cannabis demonstrates neuroprotective properties and symptom management potential in other movement disorders, understanding its role in CBD could provide clinicians with additional therapeutic options for patients facing progressive motor and [cognitive decline](https://cedclinic.com/cannabis-cognitive-safety-in-older-adults/). Clinical Summary Corticobasal degeneration is a rare neurodegenerative disease characterized by asymmetric motor symptoms including rigidity, dystonia, and apraxia, often accompanied by cognitive dysfunction. The condition typically affects adults over 60 and progresses relentlessly, with current treatments focused primarily on symptomatic management through dopaminergic medications, botulinum toxin, and supportive care. The underlying pathology involves tau protein accumulation leading to neuronal loss in cortical and subcortical regions. No disease-modifying treatments currently exist, and prognosis remains poor with most patients becoming severely disabled within 6-8 years of symptom onset. Dr. Caplan’s Take “While we lack specific research on cannabis for CBD, the endocannabinoid system’s role in motor control and neuroprotection suggests potential benefit for symptom management. I counsel families that cannabis may help with pain, sleep, and appetite issues that compound this devastating disease, though we must be realistic about limitations given CBD’s relentless progression.” Clinical Perspective 🧠 Clinicians should focus on comprehensive symptom management while monitoring for cannabis interactions with existing medications, particularly if patients are using dopaminergic agents or benzodiazepines. [Quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/) measures become paramount in CBD care, and cannabis may offer palliative benefits for secondary symptoms like pain, sleep disturbance, and mood changes that significantly impact both patients and caregivers. Any cannabis intervention should be integrated into broader multidisciplinary care planning. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Corticobasal%20Degeneration%20%7C%20Pacific%20Neuroscience%20Institute%20%40drcaplan&url=https%3A//www.pacificneuroscienceinstitute.org/condition/corticobasal-degeneration/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.pacificneuroscienceinstitute.org/condition/corticobasal-degeneration/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Corticobasal%20Degeneration%20%7C%20Pacific%20Neuroscience%20Institute%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.pacificneuroscienceinstitute.org/condition/corticobasal-degeneration/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.pacificneuroscienceinstitute.org/condition/corticobasal-degeneration/](https://www.pacificneuroscienceinstitute.org/condition/corticobasal-degeneration/) Table of Contents - [FAQ](#FAQ)[What medical conditions are being discussed in this cannabis research?](#What_medical_conditions_are_being_discussed_in_this_cannabis_research) - [What is the clinical significance of this cannabis news?](#What_is_the_clinical_significance_of_this_cannabis_news) - [Does this research suggest cannabis has neuroprotective properties?](#Does_this_research_suggest_cannabis_has_neuroprotective_properties) - [Is this research relevant for palliative care practitioners?](#Is_this_research_relevant_for_palliative_care_practitioners) - [How current is this cannabis research?](#How_current_is_this_cannabis_research) - [Related](#Related) ## FAQ #### What medical conditions are being discussed in this cannabis research? This research focuses on neurodegenerative diseases and movement disorders. The study also examines cannabis applications in palliative care settings for patients with these conditions. #### What is the clinical significance of this cannabis news? This has been rated as “Notable Clinical Interest” with a CED Clinical Relevance score of #70. It represents emerging findings or policy developments that [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) should monitor closely. #### Does this research suggest cannabis has neuroprotective properties? The research appears to explore neuroprotection as one of the key areas of interest. However, the specific findings and mechanisms would need to be detailed in the full study to draw definitive conclusions. #### Is this research relevant for palliative care practitioners? Yes, palliative care is specifically tagged as one of the relevant clinical areas. This suggests the research has implications for end-of-life care and symptom management in terminal patients. #### How current is this cannabis research? This is marked as “New” research from CED Clinic’s cannabis news section. It represents recent developments in the field that are worth noting for their potential clinical impact. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Corticobasal Degeneration | Pacific Neuroscience Institute”, “url”: “https://www.pacificneuroscienceinstitute.org/condition/corticobasal-degeneration/”, “datePublished”: “2026-03-24T10:18:56Z”, “about”: “corticobasal degeneration pacific neuroscience institute”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical Cannabis Linked to Improvements in Pain, Sleep and Nighttime Urination in …](https://cedclinic.com/medical-cannabis-linked-to-improvements-in-pain-sleep-and-nighttime-urination-in/) Discover how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) can improve pain, sleep quality, and nighttime urination, relevant for managing symptoms in neurodegenerative disorders. [Read More](https://cedclinic.com/medical-cannabis-linked-to-improvements-in-pain-sleep-and-nighttime-urination-in/) [Many studies show the efficacy of cannabis for inflammation. That's important because …](https://cedclinic.com/cannabis-anti-inflammatory-effects-research-clinical-insights/) Explore the anti-inflammatory properties of cannabis which may contribute to neuroprotection and symptom relief in movement disorders. [Learn More](https://cedclinic.com/cannabis-anti-inflammatory-effects-research-clinical-insights/) [Clinical Trial Finds Medical Cannabis Extracts Improve Cancer-Related Symptoms in About …](https://cedclinic.com/clinical-trial-finds-medical-cannabis-extracts-improve-cancer-related-symptoms-in-about/) [Clinical evidence](https://cedclinic.com/academic-partnerships-cannabis-research/) supports [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) extracts for symptom improvement, highlighting potential benefits for palliative care patients. [Explore Study](https://cedclinic.com/clinical-trial-finds-medical-cannabis-extracts-improve-cancer-related-symptoms-in-about/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).